NVS Oct 2024 87.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:45AM EDT. Market open.
| Previous close | 1.1000 |
| Open | 1.1000 |
| Bid | 1.0500 |
| Ask | 1.2000 |
| Strike | 87.50 |
| Expiry date | 2024-10-18 |
| Day's range | 1.1000 - 1.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 96 |
- Reuters
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug manufacturer said on Thursday. Mariana Oncology is working on novel radioligand cancer therapies (RLTs) that have not yet been tested on humans. "The transaction bolsters the Novartis RLT pipeline and expands the company’s research infrastructure and clinical supply capabilities," Novartis said in a statement.
Yahoo FinanceCVS stock plunges after earnings numbers one analyst 'did not even believe'
CVS warns it could cede Medicare Advantage market share as reimbursement rates pressure the company.
GuruFocus.comNovartis Is Tracking Well Above the Industry
A closer look at one of the leaders in the global cancer therapeutics market
© 2024 Yahoo. All rights reserved.